# Junta clínica — PT-pseudo_fc6cf5262222 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_fc6cf5262222",
  "pid": "PT-pseudo_fc6cf5262222",
  "task": 1,
  "psa": 7.5,
  "age": 61,
  "months": 1,
  "pirads": "4",
  "psad": 0.179,
  "psav": 1.49,
  "psap": 4.6,
  "vol": 42.0,
  "dre": "Normal",
  "bx": "Positive",
  "cspca": 0.0,
  "medhx": "Hypertension",
  "meds": "valsartan, metoprolol",
  "notes": "PSA 7.5 ng/mL. PI-RADS 4. PSAD 0.18. Prostate volume 42 mL. csPCa 0.00.",
  "pmhx": [
    "Hypertension"
  ],
  "allergies": [],
  "vitals": {
    "weight": "79 kg",
    "height": "177 cm",
    "bmi": "25.2",
    "bp": "124/76 mmHg",
    "hr": "83 bpm",
    "smoking": "Ex-smoker (34 pack-yr, quit 2006)",
    "last_dental": "3 yr ago",
    "flu_vax": "Sep 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "22 Feb 2025",
  "enc_ref": "Dr. R. Visser (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Clinical reassessment triggered by a recent PSA rise to 7.5 ng/mL and a previous biopsy bucket marked positive."
    },
    {
      "s": "History",
      "t": "A 61-year-old self-employed contractor specializing in carpentry has remained under urological observation since his initial screening in 2022. He reports an IPSS score of 2 out of 35, indicating minimal lower urinary tract symptoms, and maintains a daily 45-minute walking regimen. Alcohol consumption averages six units weekly. An ex-smoker with a 34 pack-year history who ceased tobacco use in 2006, he currently lives independently while his wife resides elsewhere and their adult son checks in regularly. Hypertension is managed with valsartan and metoprolol. A recent vascular surgery consultation addressed asymptomatic varicose veins. He denies bone pain, haematuria, or unexplained weight loss, and his surgical background includes only a minor arthroscopic knee procedure performed more than ten years ago."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: smooth and symmetric; mobility: unremarkable; asymmetry: absent.\nGeneral assessment shows stable vital signs, including a blood pressure of 124/76 mmHg and a regular pulse at 83 beats per minute. Abdominal palpation yields no detectable masses or organ enlargement."
    }
  ],
  "occupation": "self-employed contractor (carpentry)",
  "marital": "Married",
  "living": "Lives alone; adult son nearby",
  "next_of_kin": "Spouse / partner (primary contact)",
  "recent_other": [
    "Vascular surgery — varicose veins consult"
  ],
  "alcohol": "6 units / week",
  "exercise": "Walking 45 min/day",
  "ipss": "IPSS score: 2/35 (mild LUTS)",
  "admin": "Patient anxious about procedures — allocate extra consult time.",
  "mri_hospital": "Erasmus MC",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_fc6cf5262222
Task: 1

Encounter: Urology - outpatient on 22 Feb 2025.
Referrer: Dr. R. Visser (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 61-year-old male
  - PSA: 7.5 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.179 ng/mL²
  - PSA velocity: 1.49 ng/mL/yr
  - Prior PSA: 4.6 ng/mL
  - Prostate volume: 42.0 mL
  - Months since last PSA: 1
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.0 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Hypertension
  - Problem list / PMHx: Hypertension
  - Current medication: valsartan, metoprolol
  - Allergies: NKA
  - Additional notes: PSA 7.5 ng/mL. PI-RADS 4. PSAD 0.18. Prostate volume 42 mL. csPCa 0.00.

Vitals: weight 79 kg, height 177 cm, BMI 25.2, BP 124/76 mmHg, HR 83 bpm. Smoking: Ex-smoker (34 pack-yr, quit 2006).

Chief complaint: Clinical reassessment triggered by a recent PSA rise to 7.5 ng/mL and a previous biopsy bucket marked positive.

History: A 61-year-old self-employed contractor specializing in carpentry has remained under urological observation since his initial screening in 2022. He reports an IPSS score of 2 out of 35, indicating minimal lower urinary tract symptoms, and maintains a daily 45-minute walking regimen. Alcohol consumption averages six units weekly. An ex-smoker with a 34 pack-year history who ceased tobacco use in 2006, he currently lives independently while his wife resides elsewhere and their adult son checks in regularly. Hypertension is managed with valsartan and metoprolol. A recent vascular surgery consultation addressed asymptomatic varicose veins. He denies bone pain, haematuria, or unexplained weight loss, and his surgical background includes only a minor arthroscopic knee procedure performed more than ten years ago.

Physical examination: DRE — texture: smooth and symmetric; mobility: unremarkable; asymmetry: absent.
General assessment shows stable vital signs, including a blood pressure of 124/76 mmHg and a regular pulse at 83 beats per minute. Abdominal palpation yields no detectable masses or organ enlargement.

Patient info: self-employed contractor (carpentry); Married; Lives alone; adult son nearby.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 6 units / week; exercise Walking 45 min/day; IPSS score: 2/35 (mild LUTS).

Recent other appointments: Vascular surgery — varicose veins consult.
Admin: Patient anxious about procedures — allocate extra consult time.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: NO BIOPSY   p(biopsy) = 0.42
  uncertainty  +/- 0.11 epistemic (95% band 0.20-0.64); among patients I cannot tell apart the outcome was 0.98 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

What moved me most, across the labelled series: prior positive biopsy, PI-RADS >= 4, no prior biopsy, pmhx_hypercholesterolaemia, suspicious DRE, number of comorbidities. I read 39 variables, all
from the panel — nothing from the mpMRI prose, the PSA trajectory, the previous notes or the
laboratory. Out-of-fold over 91 labelled cases: AUC 0.758, balanced
accuracy 0.625.

The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 49 labelled men in this same situation (Positive prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 1.57: PI-RADS 4, PSA 8.4, PSAD 0.1, age 63, DRE Normal -> BIOPSY (uncertain). He wrote: "Patient on Active surveillance. Initial ISUP and MRI is needed."
  2. distance 1.94: PI-RADS 4, PSA 5.2, PSAD 0.151, age 68, DRE Normal -> BIOPSY (uncertain). He wrote: "Again missing earlier ISUP grading and if the PIRADS 4 lesion is stabile or growing"
  3. distance 2.19: PI-RADS 4, PSA 5.3, PSAD 0.1, age 56, DRE Nodus -> BIOPSY (clear). He wrote: "PIRADS 4 in a young man with a rapid increasing PSA"

PRECEDENT: BIOPSY (weighted vote 1.00 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.
WHAT HE WEIGHS: bx=decisive, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted.
HOW SURE HE USUALLY IS: clear.

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The EAU guidelines address the use of MRI-directed biopsy and repeat biopsy strategies based on MRI findings and prior biopsy status. "A stable MRI (PRECISE 1-3) does not make repeat biopsy superfluous but it might be excluded in patients with low-risk tumour and a stable low PSA-D < 0.15."

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, I disagree with the suggestion of no biopsy because the guideline does not provide a definitive threshold for this patient's specific combination of prior positive biopsy and PI-RADS 4. EXPERT-COHORT, the cohort criterion is insufficient because the panel does not contain the necessary information regarding the documented grade of the prior biopsy, which is a key variable the guideline makes decisive.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the documented grade of the prior biopsy: at ISUP 2 or above the guideline sends him to treatment, not to more tissue; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the PSA velocity: the rate of change is a factor that must be considered in the overall risk assessment
laboratory_results - the PSA density: this value is a factor that must be considered in the overall risk assessment

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges on establishing the documented grade of the prior biopsy and the surveillance plan detailed in the previous notes.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Determine whether the lesion is compared against an earlier study.
  psa_trend (get_psa_trend) -> Determine the PSA velocity and its relevance to the risk assessment.
  previous_notes (get_previous_notes) -> Determine the documented grade of the prior biopsy and the surveillance protocol status.

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the documented grade (Gleason/ISUP) of the prior biopsy?
  Q2. Is the lesion in the radiology report compared against an earlier study?
  Q3. What is the PSA velocity and how does it factor into the overall risk assessment?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
COMPARISON: new
LESION: size and zone of the index lesion, as the report words it: "discrete, hypointense focus in the right peripheral zone at mid-gland, spanning 14 x 11 x 10 mm."

psa_trend
PSA 2.9 (Nov 2022) rising to 7.5 (Feb 2025), steepest in the last year

previous_notes
PRIOR GRADE: not recorded
BIOPSY SESSIONS: not recorded
SURVEILLANCE: "Monitoring continued without additional procedural steps during this visit."
TREATMENT: "none recorded"

WHAT I DID NOT OPEN
I did not open the laboratory_results because the information on PSA density was not explicitly requested by the moderator's open questions.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS 4 finding from the radiology report.
PSA velocity of 1.49 ng/mL/yr from the PSA trend.
FOR against sampling this patient now
Prior biopsy status is not explicitly graded in the previous notes.

WHERE THIS LEANS
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 7.50 ng/mL over 4 points spanning 27 months; velocity +2.04 ng/mL per year; doubling time about 20 months.
PROJECTION at 6 months: 10.3 ng/mL, conformal 95% band 3.0-36.1.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.57
  uncertainty  +/- 0.11 epistemic (95% band 0.36-0.77), of which 0.01 comes from values that had to be imputed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 59% of the time over the 29 labelled cases in this tier

What moved me most across the labelled series: prior positive biopsy, no prior biopsy, free PSA < 15%, DWI restriction in the report, lesion >= 15 mm in the report, suspicious DRE. Out-of-fold AUC 0.794. I am the only expert that has read the report's wording, and I still cannot see the prior grade or the
surveillance history: those are in the notes, and the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  DEFER, p(biopsy)=0.42  ('discuss' tier; weight 1.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.57  ('discuss' tier, fusion_nolab; weight 1.5)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=1.00  (k=3 precedents; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.51 — carried by weighted panel.
PANEL ANSWER: BIOPSY. EXPERT-FUSION carried the most weight ('discuss' tier, fusion_nolab). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.
Dissenting on the board: EXPERT-STRUCTURED. Their bids are recorded above; they did not carry because a higher rung of the protocol applied.

Confidence the trace model expects here: uncertain. Weights it expects: bx=decisive, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents retrieved by the registrar—radiology_report, psa_trend, and previous_notes—directly address all three moderator questions.

ALIGNMENT WITH THE PANEL
The panel protocol concluded with a weighted vote for BIOPSY (p=0.51), which aligns with the Expert-Fusion's suggestion of BIOPSY (p=0.57).

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the documented grade (Gleason/ISUP) of the prior biopsy? The previous_notes state "PRIOR GRADE: not recorded."
Q2. Is the lesion in the radiology report compared against an earlier study? The radiology_report states "COMPARISON: new."
Q3. What is the PSA velocity and how does it factor into the overall risk assessment? The psa_trend shows a velocity of 1.49 ng/mL/yr.

WHAT CARRIES WEIGHT, AND WHY
The documented prior biopsy grade (or lack thereof) is the most critical variable, as the EAU guideline emphasizes that the documented grade dictates the next step. The PSA velocity is also important as it reflects the current rate of disease progression.

MY SUGGESTION TO THE CHAIR
Given that the documented prior grade is not recorded, and the other factors (PI-RADS 4, rising PSA velocity) lean towards intervention, I suggest proceeding with a biopsy to establish the necessary pathological baseline.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: uncertain)

61y male, PSA 7.5, PI-RADS 4, prior positive biopsy with unrecorded grade. Rising PSA trend and unrecorded prior grade mandate sampling to determine management. The lack of prior grade is the key factor driving the decision to biopsy.

What carried weight: bx=decisive, age=important, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes
